NFKB1 and cardiovascular disorder: Given the reported relevance of CRAMP in atherosclerosis, the present findings which demonstrate a strong impact of CRAMP on the activation of ROS/NF-κB/IL-6 studies and provide new insights into the mechanisms by which CRAMP can regulate oxidation signaling in cardiovascular diseases like atherosclerosis.